17 July 2012

Sodium Buildup in Brain Linked To Multiple Sclerosis Disability and Nerve Degeneration

Multiple sclerosis is an autoimmune disease that affects the brain, optic nerve, and spinal cord. The protective covering that surrounds the nerve cells called Myelin Sheaths are damaged which causes nerve signals to slow down or stop.

The damage is caused when the body's own immune system attacks the nervous system causing inflammation. Diseases where the immune system mistakenly attacks normal body cells or tissues are classified as autoimmune diseases.

Multiple sclerosis (MS) affects women more than men and although the disorder can manifest any age, it is commonly diagnosed between ages 20 and 40.

It is still unknown what causes multiple sclerosis but some factors considered are viruses, family history, or a genetic defect.

There is still no known cure for multiple sclerosis although therapies exist that may slow the progression of the disease. MS treatments focuses on controlling the symptoms to help maintain a normal quality of life.

Sodium buildup in brain linked to disability in multiple sclerosis

A buildup of sodium in the brain detected by magnetic resonance imaging (MRI) may be a biomarker for the degeneration of nerve cells that occurs in patients with multiple sclerosis (MS), according to a new study published online in the journal Radiology.

The study found that patients with early-stage MS showed sodium accumulation in specific brain regions, while patients with more advanced disease showed sodium accumulation throughout the whole brain. Sodium buildup in motor areas of the brain correlated directly to the degree of disability seen in the advanced-stage patients.

"A major challenge with multiple sclerosis is providing patients with a prognosis of disease progression," said Patrick Cozzone, Ph.D., director emeritus of the Center for Magnetic Resonance in Biology and Medicine, a joint unit of National Center for Scientific Research (CNRS) and Aix-Marseille University in Marseille, France. "It's very hard to predict the course of the disease."

In MS, the body's immune system attacks the protective sheath (called myelin) that covers nerve cells, or neurons, in the brain and spinal cord. The scarring affects the neurons' ability to conduct signals, causing neurological and physical disability. The type and severity of MS symptoms, as well as the progression of the disease, vary from one patient to another.

Video: Multiple Sclerosis

Dr. Cozzone, along with Wafaa Zaaraoui, Ph.D., research officer at CNRS, Jean-Philippe Ranjeva, Ph.D., professor in neuroscience at Aix-Marseille University and a European team of interdisciplinary researchers used 3 Tesla (3T) sodium MRI to study relapsing-remitting multiple sclerosis (RRMS), the most common form of the disease in which clearly defined attacks of worsening neurologic function are followed by periods of recovery. Sodium MRI produces images and information on the sodium content of cells in the body.

"We collaborated for two years with chemists and physicists to develop techniques to perform 3T sodium MRI on patients," Dr. Zaaraoui said. "To better understand this disease, we need to probe new molecules. The time has come for probing brain sodium concentrations."

Using specially developed hardware and software, the researchers conducted sodium MRI on 26 MS patients, including 14 with early-stage RRMS (less than five years in duration) and 12 with advanced disease (longer than five years), and 15 age- and sex-matched control participants.

In the early-stage RRMS patients, sodium MRI revealed abnormally high concentrations of sodium in specific brain regions, including the brainstem, cerebellum and temporal pole. In the advanced-stage RRMS patients, abnormally high sodium accumulation was widespread throughout the whole brain, including normal appearing brain tissue.

"In RRMS patients, the amount of sodium accumulation in gray matter associated with the motor system was directly correlated to the degree of patient disability," Dr. Zaaraoui said.

Current treatments for MS are only able to slow the progress of the disease. The use of sodium accumulation as a biomarker of neuron degeneration may assist pharmaceutical companies in developing and assessing potential treatments.

"Brain sodium MR imaging can help us to better understand the disease and to monitor the occurrence of neuronal injury in MS patients and possibly in patients with other brain disorders," Dr. Ranjeva said.


Radiological Society of North America
National Center for Scientific Research (CNRS)
Aix-Marseille University
Stress Management Program Reduces Multiple Sclerosis Disease Activity
Patients with Multiple Sclerosis Benefit with Cognitive Rehabilitation Therapy for Improved Brain Performance
New Developments on Degenerative Effects of Multiple Sclerosis
Discovery May Lead to New Therapy for Autoimmune Diseases
Walking Again After Spinal Cord Injury Through Neuroprosthetics and Robotics
Scientists Study Secret Behind Chinese Herbal Medicine
Mind Reading Device Allow Mute and Disabled To Communicate With Others